Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination

Table 4 Clinical presentation of COVID-19 and relapse of ARD after infection

Clinical presentation of COVID-19	All infections	Relapse N (%)
Asymptomatic^a	14	2 (14)
Mild^b	69	4 (6)
Moderate^c	19	3 (16)
Hospitalization^d	1	1 (100)

^a Asymptomatic infection – no reported symptoms, ^b Mild clinical presentation – loss of smell and/or taste, fever of 38 °C or less for up to two days of, mild headache and/or cough with no other symptoms, ^c Moderate clinical presentation – fever lasting more than two days or above than 38 °C, myalgia, and/or other symptoms not included in the mild clinical presentation subcategory, ^d Hospitalization – because of COVID-19 patient required hospitalization

ISSN: 1546-0096